A prospective study of the clinical efficacy of a PD/PK-based four-times-daily fractionated dosing regimen of a carbapenem antimicrobial, biapenem, for the treatment of sepsis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.